Education
About Us
Working with TipRanks
Follow Us
Agilon Health (AGL)
NYSE:AGL
Earnings Data
Report Date
Feb 25, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.22Last Year’s EPS
-0.41Same Quarter Last Year
Based on 19 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 25, 2025
|% Change Since: -14.05%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed sentiment with strong membership and revenue growth in 2024, but challenges remain with adjusted EBITDA losses, projected membership decline in 2025, and elevated medical cost trends. The reduction in Part D exposure and quality performance improvements are positive, but significant challenges in cost management persist.Company Guidance
During the agilon health Fourth Quarter 2024 Earnings Conference Call, the company provided guidance for 2025, highlighting several key metrics. For 2025, agilon expects a Medicare Advantage (MA) membership decline of approximately 4%, translating to a range of 490,000 to 520,000 members. Revenue is anticipated to decrease by 2% to $5.925 billion, primarily due to the membership decline, although this is offset by improved payor contracts and member mix changes. Medical margin is forecasted to grow by 46% to $300 million at the midpoint, despite ongoing elevated cost trends. Adjusted EBITDA is projected to be negative $75 million at the midpoint, reflecting a gross medical cost trend of 6.3%. The company also mentioned strategic actions such as reducing Part D exposure to less than 30% of membership, which is expected to help mitigate cost trend headwinds. Additionally, agilon aims to achieve cash flow breakeven by 2027.Significant MA Membership Growth
MA membership increased 36% year-over-year to 527,000 members, driven by expansion of the '24 partner class and 4.1% same geography growth.
Substantial Revenue Growth
Total revenue grew 44% in the quarter to $1.52 billion and 40% for the year to $6.06 billion, primarily driven by the class of '24 markets and organic growth.
Reduction in Part D Risk Exposure
Reduced Medicare Part-D exposure to less than 30% of membership for 2025, ahead of the previous goal of 50%.
Quality Performance Improvements
Readmission, hospital admission, and ER visit rates are 20% to 30% better than the local fee-for-service benchmark, with quality scores approaching or greater than 4.25 stars.
---
AGL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
AGL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 25, 2025 | $3.63 | $3.36 | -7.44% |
| Nov 07, 2024 | $2.79 | $1.84 | -34.05% |
| Aug 06, 2024 | $6.22 | $5.64 | -9.32% |
| May 07, 2024 | $4.98 | $5.19 | +4.22% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Agilon Health (AGL) report earnings?
Agilon Health (AGL) is schdueled to report earning on Feb 25, 2025, TBA Not Confirmed.
What is Agilon Health (AGL) earnings time?
Agilon Health (AGL) earnings time is at Feb 25, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AGL EPS forecast?
AGL EPS forecast for the fiscal quarter 2024 (Q4) is -0.22.
---